Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents.

Autor: Gelinas AD; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK., Liu S; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Jaramillo JG; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Chadwick J; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Harding AC; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Zhang C; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., Ream BE; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., Chase CN; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., Otis MR; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., Lee T; Department of Biochemistry, University of Colorado, Boulder, JSCBB, C1B90, 3415 Colorado Avenue, Boulder, CO 80303, USA., Schneider DJ; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA., James WS; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Janjic N; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Mar 14; Vol. 31, pp. 370-382. Date of Electronic Publication: 2023 Jan 21.